The full content of Annals is available to subscribers

Subscribe/Learn More  >
Original Research |

Carbenicillin: A Clinical and Laboratory Evaluation

[+] Article, Author, and Disclosure Information

Supported in part by grants AI-00329 and AI-04152, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.; by the Marcus T. Reynolds, III, Fund, Denver, Colo.; and by a grant from Pfizer Laboratories, New York, N.Y.

Presented in part October 27-29, 1969, at the Ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D.C.

▸Requests for reprints should be addressed to Theodore C. Eickhoff, M.D., Department of Medicine, University of Colorado Medical Center, 4200 E. Ninth Ave., Denver, Colo. 80220

Denver, Colorado

Ann Intern Med. 1970;73(2):179-187. doi:10.7326/0003-4819-73-2-179
Text Size: A A A

Carbenicillin therapy was given for Gram-negative infections, especially those due to Pseudomonas aeruginosa. In vitro studies demonstrated antibacterial activity against P. aeruginosa only at high drug concentrations. Forty-five patients with Gram-negative infections, including 38 due to Pseudomonas, were treated with carbenicillin. Therapy was successful in 10 patients, resulted in improvement in 19, and was considered a failure or indeterminate in 16 patients. Nine additional patients with Gram-negative infections were treated with carbenicillin and gentamicin; three were successfully treated; two improved; and four were failures or indeterminate. Carbenicillin was most effective in treating pseudomonas urinary-tract infections, although the relapse rate was high. Results of therapy for bacteremia, pneumonia, and other foci of infection were far less satisfactory, partly because of the serious nature of underlying disease. Carbenicillin-resistant Pseudomonas strains emerged during therapy in four patients. No serious drug toxicity was encountered, but superinfection was frequent.







Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $42.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.